Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The neu-oncogene: more than a prognostic indicator?

C R De Potter1

  • 1N. Goormaghtigh Institute of Pathology, University Hospital, Ghent, Belgium.

Human Pathology
|December 1, 1994
PubMed
Summary

Overexpression of the neu-protein is linked to increased breast cancer cell motility and metastasis. A specific motility factor attracts neu-overexpressing cells, driving tumor invasion in various breast cancer types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma.

Histochemistry and cell biology·2001
Same author

Localization of BRCA1 protein at the cellular level.

Journal of mammary gland biology and neoplasia·2000
Same author

Pathogenesis of Paget's disease: epidermal heregulin-alpha, motility factor, and the HER receptor family.

Journal of the National Cancer Institute·2000
Same author

Single cell and tissue specific methods for evaluation of radiation and microgravity effects.

Mutation research·2000
Same author

Cellular uptake and retention measurements of alkylphosphocholines in the SK-BR-3 breast cancer and Molt-4 leukemia cell line using capillary gas chromatography.

Lipids·1999
Same author

Osteoma cutis in pseudohypoparathyroidism.

Dermatology (Basel, Switzerland)·1999

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The neu-protein (human epidermal growth factor receptor 2) is overexpressed in a significant percentage of invasive duct cell carcinomas, in situ duct cell carcinomas, and Paget's disease of the breast.
  • Neu-protein overexpression is associated with tumor growth and plays a critical role in cancer cell motility.
  • A specific motility factor acting as a ligand for the neu-protein influences tumor cell behavior.

Purpose of the Study:

  • To investigate the role of the neu-protein and its associated motility factor in breast cancer progression.
  • To understand the mechanism by which neu-protein overexpression contributes to tumor cell metastasis.
  • To elucidate the role of neu-protein-mediated chemotaxis in Paget's disease of the breast.

Main Methods:

  • Immunohistochemistry was used to detect neu-protein expression levels in various breast cancer subtypes.
  • Studies were conducted to analyze the effect of the neu-protein motility factor on cancer cell behavior.
  • Chemotaxis assays were performed to assess the migratory response of neu-overexpressing breast cancer cells.

Main Results:

  • Neu-protein overexpression was observed in 20% of invasive duct cell carcinomas, 50% of in situ duct cell carcinomas, and nearly 100% of Paget's disease cases.
  • The neu-protein motility factor was found to induce chemotaxis in neu-overexpressing breast cancer cells.
  • In Paget's disease, a motility factor from epidermal keratinocytes attracts neu-overexpressing Paget's cells, leading to epidermal invasion.

Conclusions:

  • Neu-protein overexpression is a significant factor in promoting breast cancer cell motility and potentially increasing metastatic potential.
  • The neu-protein motility factor-induced chemotaxis is a key mechanism driving tumor cell invasion.
  • These findings highlight the neu-protein's role in the pathogenesis of breast cancer, including Paget's disease.

Related Experiment Videos